Affymetrix introduces cost-effective, high-throughput Axiom 384HT format for genotyping

NewsGuard 100/100 Score

Affymetrix, Inc. (NASDAQ: AFFX) announces the introduction of the Axiom® 384HT genotyping format, a breakthrough cost-effective, high-throughput format for genotyping in which 384 samples are simultaneously processed with 384 discrete microarrays in a microplate format analyzing up to 50,000 SNPs per sample.

“The Limagrain production facilities are the first in the world to achieve the capability to screen thousands of SNPs across many thousands of plant samples in a rapid, affordable, and routine manner with the 384-array format.”

The array content of the new Axiom 384HT format is fully customizable, supporting applications ranging from detailed assessment of human disease to high-throughput agricultural screening and marker-assisted breeding. This new 384-array format runs seamlessly on the existing GeneTitan® Multichannel Instrument, providing researchers with a flexible choice of array formats on a single automated platform for highly cost-effective identification, validation, and screening of complex genetic traits.

"This latest addition to the Axiom genotyping platform uniquely addresses a trend in both the human and agrigenomics fields of study using population-optimized or application-focused content in conjunction with low operating cost," said Andy Last, Executive Vice President of Genetic Analysis and Clinical Applications Business Unit at Affymetrix. "The new format increases throughput per system by fourfold, meeting the expanding demands of targeted genotyping on very large numbers of samples at a significantly reduced cost. Custom arrays can be manufactured and delivered to customers in as little as four to six weeks."

Limagrain, a French agricultural cooperative and the fourth largest seed company in the world, has adopted the Axiom 384HT format for routine genotyping of a number of plants using the Axiom myDesign™ multi-species custom arrays in the 384-layout.

"We are very excited to adopt the Axiom 384HT format in our routine genotyping program. This will give us the capacity to run systematic marker-assisted selection with very large sets of markers to improve the yield and quality of all our crops, which will result in a strong acceleration of the various breeding programs at Limagrain," said Dr. Jean-Pierre Martinant, Deputy Head of Research Support Functions for Limagrain Europe. "The Limagrain production facilities are the first in the world to achieve the capability to screen thousands of SNPs across many thousands of plant samples in a rapid, affordable, and routine manner with the 384-array format."

The new Axiom 384HT format addresses a current market need by providing scientists with a very economical method of quickly genotyping samples across up to 50,000 markers. Scientists can transfer content from Axiom 96-layout arrays used in sequencing validation and GWAS studies to Axiom 384-layout arrays with 100% fidelity and functionality. The high-throughput assay combined with the Axiom software for automated genotype calling in diploid and complex polyploid species offers an elegant and superior platform for routine genotyping applications.

As scientists make progress in decoding the genomes of various human disease states, they can advance their research and commercial objectives by translating those discoveries into applications for routine human disease screening using custom arrays in the 384-layout.

Researchers designing custom genotyping arrays receive design support and expertise from Affymetrix' team of bioinformatics scientists to ensure streamlined SNP selection and intelligently designed arrays that fulfill the specific objectives of their study. The Axiom genotyping platform is the only platform that offers the capability to genotype 384 samples across 50,000 markers simultaneously and affordably genotype large sample collections quickly.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rising antibiotic resistance prompts shift to ecological research strategies in infection control